IE40599L - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- IE40599L IE40599L IE750278A IE27875A IE40599L IE 40599 L IE40599 L IE 40599L IE 750278 A IE750278 A IE 750278A IE 27875 A IE27875 A IE 27875A IE 40599 L IE40599 L IE 40599L
- Authority
- IE
- Ireland
- Prior art keywords
- potentiator
- mixture
- weight
- meaning given
- tablet formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
Abstract
2,4-Diamino-5-benzylpyrimidines of the accompanying formula I, in which R<1>, R<2> and R<3> have the meaning given in the Patent Claim, which are contained as a potentiator for sulphonamides in tablets in which a mixture of sulphonamide and potentiator is present in an amount of 80 to 95% by weight, the mixture having a particle size of less than 40 mu m, and which additionally contain a granulating agent and a disintegrating agent which has a swelling capacity of more than 5 ml/g, the total amount of the two agents being not more than 20% by weight, are prepared by reacting a compound of the accompanying formula II, in which X, Y and Z have the meaning given in the Patent Claim, with guanidine and purifying and isolating the process product. <IMAGE>
[GB1499672A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB6758/74A GB1499672A (en) | 1974-02-14 | 1974-02-14 | Tablet formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE40599L true IE40599L (en) | 1975-08-14 |
| IE40599B1 IE40599B1 (en) | 1979-07-04 |
Family
ID=9820242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE278/75A IE40599B1 (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
Country Status (32)
| Country | Link |
|---|---|
| JP (1) | JPS5545043B2 (en) |
| AT (1) | AT344915B (en) |
| AU (1) | AU468465B2 (en) |
| BE (1) | BE825496A (en) |
| CA (1) | CA980688A (en) |
| CH (1) | CH618432A5 (en) |
| CS (1) | CS220306B2 (en) |
| CY (1) | CY1052A (en) |
| DD (1) | DD118228A5 (en) |
| DE (1) | DE2506099C2 (en) |
| DK (1) | DK143247C (en) |
| DO (1) | DOP1979002763A (en) |
| ES (1) | ES434688A1 (en) |
| FI (1) | FI62219C (en) |
| FR (1) | FR2260993B1 (en) |
| GB (1) | GB1499672A (en) |
| GT (1) | GT197960431A (en) |
| HK (1) | HK23980A (en) |
| HU (1) | HU171536B (en) |
| IE (1) | IE40599B1 (en) |
| IL (1) | IL46629A (en) |
| IN (1) | IN141019B (en) |
| KE (1) | KE3038A (en) |
| LU (1) | LU71835A1 (en) |
| MC (1) | MC1053A1 (en) |
| MY (1) | MY8100054A (en) |
| NL (1) | NL157501C (en) |
| NO (1) | NO146043C (en) |
| PH (1) | PH14575A (en) |
| SE (1) | SE427898B (en) |
| ZA (1) | ZA75930B (en) |
| ZM (1) | ZM1875A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1533243A (en) * | 1975-02-13 | 1978-11-22 | Wellcome Found | Tablet formulation |
| US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| HU183408B (en) | 1981-04-28 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing oral ratard pharmaceutical compositions |
| GB8603964D0 (en) * | 1986-02-18 | 1986-03-26 | Cooper Animal Health Ltd | Compositions |
| GB8915716D0 (en) * | 1989-07-08 | 1989-08-31 | Coopers Animal Health | Pharmaceutical compositions |
| US5190760A (en) * | 1989-07-08 | 1993-03-02 | Coopers Animal Health Limited | Solid pharmaceutical composition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1445983A (en) * | 1972-11-06 | 1976-08-11 | Wellcome Found | Pharmaceutical formulations |
-
1974
- 1974-02-14 GB GB6758/74A patent/GB1499672A/en not_active Expired
-
1975
- 1975-02-13 NL NL7501680.A patent/NL157501C/en not_active IP Right Cessation
- 1975-02-13 PH PH16805A patent/PH14575A/en unknown
- 1975-02-13 AU AU78170/75A patent/AU468465B2/en not_active Expired
- 1975-02-13 ZA ZA00750930A patent/ZA75930B/en unknown
- 1975-02-13 DK DK52875A patent/DK143247C/en not_active IP Right Cessation
- 1975-02-13 JP JP1838875A patent/JPS5545043B2/ja not_active Expired
- 1975-02-13 MC MC751136A patent/MC1053A1/en unknown
- 1975-02-13 LU LU71835A patent/LU71835A1/xx unknown
- 1975-02-13 BE BE153330A patent/BE825496A/en not_active IP Right Cessation
- 1975-02-13 CY CY1052A patent/CY1052A/en unknown
- 1975-02-13 IN IN270/CAL/75A patent/IN141019B/en unknown
- 1975-02-13 CA CA219,982A patent/CA980688A/en not_active Expired
- 1975-02-13 FR FR7504470A patent/FR2260993B1/fr not_active Expired
- 1975-02-13 DD DD184168A patent/DD118228A5/xx unknown
- 1975-02-13 IE IE278/75A patent/IE40599B1/en unknown
- 1975-02-13 FI FI750398A patent/FI62219C/en not_active IP Right Cessation
- 1975-02-13 SE SE7501595A patent/SE427898B/en not_active IP Right Cessation
- 1975-02-13 AT AT108475A patent/AT344915B/en not_active IP Right Cessation
- 1975-02-13 ES ES434688A patent/ES434688A1/en not_active Expired
- 1975-02-13 ZM ZM18/75A patent/ZM1875A1/en unknown
- 1975-02-13 HU HU75WE00000519A patent/HU171536B/en unknown
- 1975-02-13 CH CH174775A patent/CH618432A5/en not_active IP Right Cessation
- 1975-02-13 NO NO750467A patent/NO146043C/en unknown
- 1975-02-13 CS CS75927A patent/CS220306B2/en unknown
- 1975-02-13 IL IL46629A patent/IL46629A/en unknown
- 1975-02-13 DE DE2506099A patent/DE2506099C2/en not_active Expired
-
1979
- 1979-05-14 DO DO1979002763A patent/DOP1979002763A/en unknown
- 1979-11-12 GT GT197960431A patent/GT197960431A/en unknown
-
1980
- 1980-03-28 KE KE3038A patent/KE3038A/en unknown
- 1980-05-01 HK HK239/80A patent/HK23980A/en unknown
-
1981
- 1981-12-30 MY MY54/81A patent/MY8100054A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1421964A (en) | Process for the production of sustained release pharmaceutical preparations | |
| ES8105694A1 (en) | Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals. | |
| AU6291986A (en) | Vitamin-containing granules and production thereof | |
| ES8106654A1 (en) | Pharmaceutical composition containing Sanguinaria and Galangal suitable for treatment of periodentitis and tumours. | |
| IE791172L (en) | Pharmaceutical compositions containing urea | |
| IE43901L (en) | Pharmaceutical compositions | |
| JPS57180602A (en) | Production of water-soluble chitosan derivative and film-forming agent comprising same | |
| IE40599L (en) | Tablet formulation | |
| IL38972A (en) | Substituted phenyl alkanol derivatives,their preparation and compositions containing them | |
| AU528098B2 (en) | Analgesic tablet | |
| GB1473795A (en) | Nonapeptide amides having hormonal activity | |
| JPS552601A (en) | Anti-tumor agent for non-injection use | |
| IL59603A (en) | Peptides having ubiquitin-like activity,their preparation and pharmaceutical compositions containing them | |
| GB1271466A (en) | Thiocarbamic acid derivatives | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| IE44041L (en) | Fire-extinguishing composition. | |
| JPS5543165A (en) | Amphoteric hydroxyethylcellulose derivative, its preparation, and cosmetic containing the same | |
| US2608508A (en) | N-amylsulfamyl benzoic acids | |
| JPS5651443A (en) | Preparation of methylenedicarbanilate | |
| GB1437788A (en) | Therapeutic compositions | |
| ES8502689A1 (en) | Benzazepine derivatives, process for their preparation and their use as pharmaceutical compounds. | |
| JPS5686105A (en) | Pesticide powder | |
| JPS55141438A (en) | Preparation of ground mono-basic aluminum acetylsalicylate | |
| GB1312891A (en) | Composition containing penicillin salts | |
| JPS5758890A (en) | Preparation of glucosylmoranoline derivative |